Owing to the function of PPM1D as an oncogene and the relatively mild phenotype of PPM1D depletion in adult mice (Uyanik et al., 2021), PPM1D inhibitors are being evaluated as anti-cancer drugs. This evidence concerns the gene PPM1D and cancer.